{
  "main_header": {
    "sid": 683231,
    "name": "Zenotech Lab.",
    "stock_name": "Zenotech Lab.",
    "full_name": "Zenotech Laboratories Ltd",
    "name_url": "stocks-analysis/zenotech-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "44.50",
    "chg": -0.39,
    "chgp": "-0.87%",
    "dir": -1,
    "prev_price": "44.89",
    "mcapval": "274.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532039,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE486F01012",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "3.13 k",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/zenotech-lab-683231-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Zenotech Laboratories Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zenotech-laboratories-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-3998334",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZenotechLaborat_mojoScore_3998334.png",
        "date": "2026-05-19 08:39:20",
        "description": "Zenotech Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The downgrade reflects deteriorating fundamentals, weak quarterly results, and increasingly bearish technical signals, signalling caution for investors in this micro-cap pharmaceutical stock."
      }
    ],
    "total": 15,
    "sid": "683231",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/zenotech-laboratories-683231"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "29-Jul-2026",
      "details": "Publication of extract of Unaudited Financial Results for the quarter ended June 30 2026 in newspapers.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. July 28 2026",
      "datetime": "28-Jul-2026",
      "details": "Outcome of the Board Meeting held today i.e. July 28 2026",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Financial Results For The Quarter Ended June 30 2026",
      "datetime": "28-Jul-2026",
      "details": "Submission of Unaudited Financial Results of the Company for the quarter ended June 30 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Zenotech Laboratories Ltd has announced <strong>17:22</strong> rights issue, ex-date: 01 Jun 17",
          "dt": "2017-06-01",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Zenotech Laboratories Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals

2026-05-19 08:39:20

Zenotech Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The downgrade reflects deteriorating fundamentals, weak quarterly results, and increasingly bearish technical signals, signalling caution for investors in this micro-cap pharmaceutical stock.

Read More

View All News